Raymond James Financial Services Advisors Inc. Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Raymond James Financial Services Advisors Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 794,734 shares of the healthcare conglomerate's stock after acquiring an additional 5,600 shares during the period. Raymond James Financial Services Advisors Inc. owned 0.09% of UnitedHealth Group worth $393,155,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. Richelieu Gestion SA purchased a new position in UnitedHealth Group during the 4th quarter worth $26,000. Robbins Farley purchased a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $25,000. CGC Financial Services LLC increased its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $31,000. Finally, NewSquare Capital LLC increased its stake in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 51 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Down 1.1 %

UNH traded down $5.33 during trading on Tuesday, hitting $483.70. 3,366,904 shares of the company's stock were exchanged, compared to its average volume of 4,466,545. The stock has a 50 day moving average price of $484.44 and a 200 day moving average price of $513.42. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The firm has a market cap of $445.04 billion, a P/E ratio of 29.57, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the company posted $6.26 EPS. UnitedHealth Group's revenue for the quarter was up 8.6% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group's dividend payout ratio (DPR) is presently 45.97%.

Analyst Ratings Changes

UNH has been the topic of a number of analyst reports. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating on the stock in a report on Monday, April 8th. Truist Financial restated a "buy" rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Cantor Fitzgerald reiterated an "overweight" rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. HSBC raised UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $460.00 price target for the company in a research note on Thursday, April 4th. Finally, Piper Sandler upped their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an "overweight" rating in a report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.